BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19670386)

  • 21. Significance of Wedensky Modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter-defibrillator.
    Elgarhi N; Kreuz J; Balta O; Nickenig G; Hoium H; Lewalter T; Schwab JO
    Heart; 2008 Apr; 94(4):e16. PubMed ID: 17639096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten-year follow-up of cardiac sympathectomy in a young woman with catecholaminergic polymorphic ventricular tachycardia and an implantable cardioverter defibrillator.
    Makanjee B; Gollob MH; Klein GJ; Krahn AD
    J Cardiovasc Electrophysiol; 2009 Oct; 20(10):1167-9. PubMed ID: 19298566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiac arrest caused by coronary arterial vasospasm].
    Müllertz KM; Hansen HS
    Ugeskr Laeger; 2012 Jun; 174(24):1676-7. PubMed ID: 22681995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R; Rosenfeld L; Batsford W; Lee F; McPherson C
    Circulation; 1994 Jul; 90(1):241-7. PubMed ID: 8026004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should an implanted defibrillator be considered in patients with vasospastic angina?
    Eschalier R; Souteyrand G; Jean F; Roux A; Combaret N; Saludas Y; Clerfond G; Barber-Chamoux N; Citron B; Lusson JR; Brugada P; Motreff P
    Arch Cardiovasc Dis; 2014 Jan; 107(1):42-7. PubMed ID: 24373622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
    Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter defibrillator as therapeutic option for sudden cardiac death secondary to severe coronary vasospasm.
    Fuertes J; Gallego P; Peinado R; Merino JL
    Int J Cardiol; 1998 Jan; 63(2):181-3. PubMed ID: 9510493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular tachyarrhythmias in patients receiving an implantable cardioverter-defibrillator for primary versus secondary prophylaxis indications.
    Manuchehry A; Agusala K; Montevecchi M; Kadish A; Passman R
    Pacing Clin Electrophysiol; 2011 May; 34(5):571-6. PubMed ID: 21208242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies.
    Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M
    Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
    Grimm W; Plachta E; Maisch B
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stent and implantable cardioverter defibrillator implantation in medically resistant vasospastic angina patient.
    Özyüncü N; Göksülük H; Vurgun VK; Yıldırım O; Tan Kürklü TS
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):641-645. PubMed ID: 28990946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
    Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
    Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternating atrial pacing cycle length during ventricular tachycardia: what is the mechanism?
    Almehairi M; Somani R; Michael KA; Baranchuk A
    Heart Rhythm; 2013 Oct; 10(10):1553-5. PubMed ID: 23721945
    [No Abstract]   [Full Text] [Related]  

  • 38. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variant Angina and Aborted Sudden Cardiac Death.
    Kundu A; Vaze A; Sardar P; Nagy A; Aronow WS; Botkin NF
    Curr Cardiol Rep; 2018 Mar; 20(4):26. PubMed ID: 29520510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian pattern of ventricular tachycardia episodes in patients with Chagas heart disease.
    Abello M; González-Zuelgaray J; Daglio ME; Lopez C; Garraza S; Szyszko A
    Arq Bras Cardiol; 2007 Feb; 88(2):240-2. PubMed ID: 17384844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.